Sulfamoilarilamidas derived Compounds, Pharmaceutical composition that is useful for the Prevention or treatment of an infection by the hepatitis B virus (HBV).
LAST STEFAAN JULIEN,VANDYCK KOEN,ROMBOUTS GEERT,VERSCHUEREN WIN GASTON,RABOISSON PIERRE JEAN MARIE BERNARD
申请号：
CL2015000487
公开号：
CL2015000487A1
申请日:
2015.02.27
申请国别(地区):
CL
年份:
2015
代理人:
摘要：
Inhibitors of HBV replication of Formula (I) including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein B, R1, R2 and R4 have the meaning as defined herein. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HBV inhibitors, in HBV therapy.COMPUESTOS DERIVADOS DE SULFAMOILARILAMIDAS CON ACTIVIDAD INHIBIDORA DE VHB； COMPOSICIÓN FARMACÉUTICA QUE LOS COMPRENDE Y USO EN EL TRATAMIENTO DE INFECCIONES POR VHB.
